Comment by
prophetoffactz on Jun 11, 2024 10:35pm
If avenanthramide could treat inflammation and cartilage degradation in osteoarthritis that could be a competitive advantage. In summary, the provided search results indicate that a significant proportion, ranging from 20-44% in the studies cited, of OA patients use NSAIDs for pain management, despite concerns about their potential adverse effects with long-term use.